Showing of 419 reports & studies
How global ethylene acrylic acid copolymer supply is scaling across petrochemical feedstocks, polymerisation technologies and downstream packaging, industrial and specialty material applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-419
250 pages
Chemicals & Materials
How global fluconazole supply is scaling across API manufacturing hubs, synthetic process routes and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-418
250 pages
Chemicals & Materials
How global fluorspar supply is scaling across mining operations, beneficiation technologies and downstream chemical, metallurgical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-417
250 pages
Chemicals & Materials
How global fly ash supply is evolving alongside coal-fired power generation, beneficiation technologies and downstream construction and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-416
250 pages
Chemicals & Materials
How global fumed silica supply is evolving across flame hydrolysis production systems, specialty materials manufacturing hubs and downstream performance-driven applications, where production capacity is concentrated, and what growth drivers and risks executives monitor.
January 2026
REP-GB-415
250 pages
Chemicals & Materials
How global gentamicin sulfate supply is scaling across fermentation capacity, antibiotic active pharmaceutical ingredient (API) manufacturing and downstream human and veterinary pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-414
250 pages
Chemicals & Materials
How global glutaraldehyde supply is scaling across petrochemical feedstocks, aldehyde synthesis technologies and downstream industrial, healthcare and water treatment applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-413
250 pages
Chemicals & Materials
How global graphite supply is scaling across mining assets, beneficiation and purification technologies, battery material processing and downstream industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-412
250 pages
Chemicals & Materials
How global Hastelloy supply is scaling across nickel-based superalloy melting routes, downstream industrial fabrication and high-performance end-use sectors, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-411
250 pages
Chemicals & Materials
How global iso-butyric acid supply is scaling across petrochemical and bio-based production routes, downstream chemical intermediates and specialty applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-410
250 pages
Chemicals & Materials
How global ivermectin supply is shaped by fermentation capacity, pharmaceutical manufacturing systems and downstream human and veterinary applications, where production clusters are concentrated, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-409
250 pages
Chemicals & Materials
How global lactic acid supply is scaling across fermentation feedstocks, bioprocessing technologies and downstream food, pharmaceutical and bioplastics applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-408
250 pages
Chemicals & Materials
How global levocetirizine dihydrochloride supply is scaling across pharmaceutical synthesis routes, regulatory manufacturing frameworks and downstream allergy and respiratory therapeutics, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-407
250 pages
Chemicals & Materials
How global levofloxacin hemihydrate supply is scaling across synthetic and chiral resolution routes, pharmaceutical manufacturing hubs and downstream oral and injectable antibiotic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-406
250 pages
Chemicals & Materials
How global lincomycin hydrochloride supply is evolving across fermentation capacity, pharmaceutical manufacturing systems and downstream therapeutic applications, where production clusters are located, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-405
250 pages
Chemicals & Materials
How global lithium metal supply is scaling across brine and mineral feedstocks, conversion and refining technologies and downstream battery, chemical and specialty applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-404
250 pages
Chemicals & Materials
How global lopinavir supply is scaling across API synthesis routes, regulatory manufacturing hubs and downstream pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-403
250 pages
Chemicals & Materials
How global lorazepam supply is shaped by API synthesis capacity, regulated pharmaceutical manufacturing and downstream clinical applications, where production clusters are located, and what growth drivers and risks industry stakeholders need to monitor.
January 2026
REP-GB-402
250 pages
Chemicals & Materials
How global losartan potassium supply is scaling across API synthesis routes, formulation demand and regulated pharmaceutical markets, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-401
250 pages
Chemicals & Materials
How global lovocetirizine dihydrochloride supply is scaling across pharmaceutical synthesis routes, regulatory manufacturing frameworks and downstream allergy and respiratory therapeutics, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-400
250 pages
Chemicals & Materials
How global magnesium chloride supply is scaling across natural brines, seawater extraction and chemical synthesis routes and downstream industrial, construction and environmental applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-399
250 pages
Chemicals & Materials
How global magnesium stearate supply is scaling across fatty acid feedstocks, excipient manufacturing technologies and downstream pharmaceutical, nutraceutical and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-398
250 pages
Chemicals & Materials
How global methyl-n-propyl-ketone supply is scaling across petrochemical feedstocks, solvent production routes and downstream industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-397
250 pages
Chemicals & Materials
How global methyldopa supply is scaling across API synthesis routes, pharmaceutical manufacturing hubs and downstream antihypertensive applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-396
250 pages
Chemicals & Materials
How global metoclopramide hydrochloride supply is scaling across active pharmaceutical ingredient manufacturing hubs, synthesis technologies and downstream formulation applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-395
250 pages
Chemicals & Materials
How global metoprolol succinate supply is scaling across active pharmaceutical ingredient manufacturing, controlled-release formulation technologies and downstream cardiovascular therapy demand, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-394
250 pages
Chemicals & Materials
How global metronidazole supply is scaling across pharmaceutical manufacturing hubs, synthesis routes and downstream therapeutic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-393
250 pages
Chemicals & Materials
How global mineral turpentine oil supply is scaling across refinery streams, hydrocarbon processing routes and downstream industrial, coatings and household applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-392
250 pages
Chemicals & Materials
How global minoxidil supply is scaling across active pharmaceutical ingredient manufacturing, topical formulation technologies and downstream dermatology and cardiovascular applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-391
250 pages
Chemicals & Materials
How global moxifloxacin hydrochloride supply is scaling across synthetic pharmaceutical manufacturing routes, regulated API production hubs and downstream human healthcare applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-390
250 pages
Chemicals & Materials
How global naltrexone hydrochloride supply is scaling across pharmaceutical active ingredient manufacturing, formulation technologies and downstream addiction treatment and specialty therapeutic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-389
250 pages
Chemicals & Materials
How global neomycin sulphate supply is developing across fermentation-based antibiotic manufacturing, pharmaceutical production hubs and downstream medical applications, where capacity is concentrated, and what growth drivers and operational risks decision makers need to track.
January 2026
REP-GB-388
250 pages
Chemicals & Materials
How global nitroxoline supply is evolving across pharmaceutical synthesis routes, regulatory manufacturing frameworks and downstream therapeutic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-387
250 pages
Chemicals & Materials
How global nonylphenol supply is evolving across petrochemical feedstocks, alkylation technologies and downstream industrial and specialty chemical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-386
250 pages
Chemicals & Materials
How global ofloxacin supply is scaling across fluoroquinolone synthesis routes, API manufacturing hubs and downstream human and veterinary pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-385
250 pages
Chemicals & Materials
How global omeprazole supply is scaling across pharmaceutical synthesis routes, regulated manufacturing hubs and downstream formulation and therapeutic applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-384
250 pages
Chemicals & Materials
How global orlistat supply is developing across pharmaceutical synthesis routes, regulated API manufacturing hubs and downstream obesity management applications, where production capacity is concentrated, and what structural drivers and risks industry leaders need to monitor.
January 2026
REP-GB-383
250 pages
Chemicals & Materials
How global pantoprazole sodium supply is evolving across pharmaceutical synthesis routes, regulated API manufacturing hubs and downstream gastrointestinal therapeutics, where production capacity is concentrated, and what demand drivers and operational risks industry leaders need to monitor.
January 2026
REP-GB-382
250 pages
Chemicals & Materials
How global phosphonate supply is scaling across phosphorus chemistry routes, industrial processing systems and downstream water treatment, agriculture and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-381
250 pages
Chemicals & Materials
How global polyphenylene sulfide supply is scaling across specialty polymer synthesis routes, compounding capacity and downstream high-performance industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-380
250 pages
Chemicals & Materials
How global polysorbate supply is scaling across oleochemical feedstocks, ethoxylation technologies and downstream pharmaceutical, food and industrial applications, where production clusters are located, and what growth drivers and risks decision makers need to monitor.
January 2026
REP-GB-379
250 pages
Chemicals & Materials
How global povidone supply is scaling across vinylpyrrolidone synthesis routes, polymerisation technologies and downstream pharmaceutical, personal care, food and industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-378
250 pages
Chemicals & Materials
How global propyl paraben supply is scaling across esterification chemistry, preservative demand in personal care, pharmaceuticals and food applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-377
250 pages
Chemicals & Materials
How global rabeprazole supply is scaling across proton pump inhibitor synthesis routes, API manufacturing hubs and downstream gastrointestinal pharmaceutical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-376
250 pages
Chemicals & Materials
How global ritonavir supply is scaling across API manufacturing hubs, complex synthesis routes and downstream antiretroviral and combination therapy applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-375
250 pages
Chemicals & Materials
How global salicylic acid supply is scaling across phenol-based synthesis routes, pharmaceutical and personal care demand, and downstream chemical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-374
250 pages
Chemicals & Materials
How global sodium ascorbate supply is scaling across vitamin C production routes, pharmaceutical and food-grade manufacturing systems, and downstream healthcare, nutrition and food applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-373
250 pages
Chemicals & Materials
How global sodium chlorite supply is scaling across chlor-alkali integration, oxidation technologies and downstream water treatment, pulp and paper, and chemical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-372
250 pages
Chemicals & Materials
How global sodium gluconate supply is scaling across carbohydrate-based fermentation routes, chemical processing hubs and downstream industrial applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-371
250 pages
Chemicals & Materials
How global sodium thiosulphate supply is scaling across sulphur chemistry routes, chlor-alkali and sulphur recovery integration, and downstream industrial, mining, photographic, water treatment and medical applications, where production clusters sit, and what growth drivers and risks executives need to watch.
January 2026
REP-GB-370
250 pages
Chemicals & Materials
